ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2025.12964 ETM-30-5-12964 Retraction [Retracted] Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway LiZhiqiang XuRenjie ZhangXiangxin ShenJun ChenGuangxiang ZouTianming YuXiao 112025 08092025 30 5 214 Copyright: © 2025 Li et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Exp Ther Med 19:1379–1387, 2020; DOI: 10.3892/etm.2019.8352

Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that flow cytometric (FCM) assay data featured in Figs. 4B and 5B were strikingly similar to FCM data which were ultimately published in a number of other papers in different journals that were written by different authors at different research institutes, including an article that was received in advance of this one to the journal Molecular Medicine Reports.

Owing to the fact that the contentious data in the above article were found to be strikingly similar to data that have appeared elsewhere in other papers in the scientific literature, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.